Yousif I. A-Rahim

CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease

David J. Friedman, Beat Künzli, Yousif I. A-Rahim et al. · Proceedings of the National Academy of Sciences · 2009 · 280 citations · Full text

Chronic Inflammatory Diseases, Immunology, Genetic Epidemiology +17

Heme Oxygenase-1-Generated Biliverdin Ameliorates Experimental Murine Colitis

Pascal O. Berberat, Yousif I. A-Rahim, Kenichiro Yamashita et al. · Inflammatory Bowel Diseases · 2005 · 113 citations · Full text

Studies on interindividual variations of CYP2E1 using chlorzoxazone as an in vivo probe

Elliot S. Vesell, Theresa DeAngelo Seaton, Yousif I. A-Rahim · Pharmacogenetics · 1995 · 28 citations

Pharmacotherapy, Pre-clinical Pharmacology, Molecular Pharmacology +16

Metabolism and Disposition of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone (NNK) in Rhesus Monkeys

Michael Meger, E. Richter, Wolfgang Zwickenpflug et al. · Drug Metabolism and Disposition · 1999 · 19 citations

Heightened NTPDase-1/CD39 expression and angiogenesis in radiation proctitis

Sunil G. Sheth, Wissam Bleibel, Chandrashekhar Thukral et al. · Purinergic Signalling · 2009 · 11 citations · Full text

Ntpdase-1/cd39 Expression, Radiation Medicine, Angiogenesis +6